{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:25:16Z","timestamp":1791329116057,"version":"4.3.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.lpm.2009.02.013","type":"journal-article","created":{"date-parts":[[2009,4,13]],"date-time":"2009-04-13T02:05:57Z","timestamp":1239588357000},"page":"964-972","source":"Crossref","is-referenced-by-count":4,"title":["Maladie coronaire chez les patients diab\u00e9tiques"],"prefix":"10.1016","volume":"38","author":[{"given":"Claude","family":"Le Feuvre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2009.02.013_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth joint tack force of the ESC and other societies on cardiovascular disease prevention in clinical practice","volume":"28","author":"Graham","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2009.02.013_bib2","first-page":"229","article-title":"SFC\/ALFEDIAM Groupe de travail. Recommandations SFC\/ALFEDIAM sur la prise en charge du patient diab\u00e9tique vu par le cardiologue","volume":"97","author":"Charbonnel","year":"2004","journal-title":"Arch Mal C\u0153ur"},{"key":"10.1016\/j.lpm.2009.02.013_bib3","unstructured":"Traitement m\u00e9dicamenteux du diab\u00e8te de type 2\u00a0: traitement m\u00e9dicamenteux des facteurs de risques vasculaires associ\u00e9s. HAS 2006: http:\/\/www.has-sante.fr."},{"key":"10.1016\/j.lpm.2009.02.013_bib4","unstructured":"Les recommandations HAS-2005 sur la prise en charge des patients adultes atteints d\u2019hypertension art\u00e9rielle. http:\/\/www.sfhta.org."},{"key":"10.1016\/j.lpm.2009.02.013_bib5","unstructured":"Afssaps. Prise en charge th\u00e9rapeutique du patient dyslipid\u00e9mique. Recommandations mars 2005. http:\/\/www.afssaps.fr\/var\/afssaps_site\/storage\/original\/application\/da2c055ce7845afe44d7aaca7c3f4de8.pdf."},{"key":"10.1016\/j.lpm.2009.02.013_bib6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jacc.2006.12.048","article-title":"PROactive Investigators. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study","volume":"49","author":"Erdmann","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2009.02.013_bib7","first-page":"338","article-title":"Identification de l\u2019isch\u00e9mie myocardique chez le diab\u00e9tique. Recommandations conjointes SCF\/ALFEDIAM","volume":"97","author":"Puel","year":"2004","journal-title":"Arch Mal C\u0153ur"},{"key":"10.1016\/j.lpm.2009.02.013_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1262-3636(07)70179-9","article-title":"Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes","volume":"31","author":"Le Feuvre","year":"2005","journal-title":"Diabetes Met"},{"key":"10.1016\/j.lpm.2009.02.013_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1590\/S0004-27302007000200018","article-title":"Silent myocardial ischemia screening in patients with diabetes mellitus","volume":"51","author":"Barth\u00e9l\u00e9my","year":"2007","journal-title":"Arq Bras Endocrinol Metab"},{"key":"10.1016\/j.lpm.2009.02.013_bib10","first-page":"849","article-title":"Cumulative adverse effect of diabetes mellitus and hypertension on coronary flow velocity reserve","volume":"97","author":"Le Feuvre","year":"2004","journal-title":"Arch Mal Coeur"},{"key":"10.1016\/j.lpm.2009.02.013_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.acvd.2008.06.015","article-title":"Intensive care of cardiovascular risk factors and prevalence of silent myocardial ischemia in type 2 diabetic patients","volume":"101","author":"Barth\u00e9l\u00e9my","year":"2008","journal-title":"Archives of Cardiovascular Disease"},{"key":"10.1016\/j.lpm.2009.02.013_bib12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/eurheartj\/ehi199","article-title":"DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity","volume":"26","author":"Malmberg","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2009.02.013_bib13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/eurheartj\/ehi138","article-title":"Guidelines for PCI","volume":"26","author":"Silber","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2009.02.013_bib14","first-page":"1598","article-title":"Guidelines for the diagnosis and treatment of non-ST-segment elevation ACS","volume":"28","author":"Bassand","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2009.02.013_bib15","first-page":"88","article-title":"Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. The task force on diabetes and cardiovascular disease of the ESC and of the EASD","volume":"28","author":"Ryden","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2009.02.013_bib16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMoa044372","article-title":"Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients","volume":"353","author":"Dibra","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2009.02.013_bib17","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2009.02.013_bib18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jtcvs.2006.05.051","article-title":"Treatment decisions in stable coronary disease in a broad range of European practices. Insights from the euro heart survey on coronary revascularization","volume":"132","author":"Breeman","year":"2006","journal-title":"J Thor Cardiovasc Surg"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209001547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209001547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T08:18:52Z","timestamp":1558253932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498209001547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0755498209001547"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2009.02.013","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}